1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1797630654913970176 |
---|---|
author | Jun Ishihara |
author_facet | Jun Ishihara |
author_sort | Jun Ishihara |
collection | DOAJ |
first_indexed | 2024-03-11T11:11:14Z |
format | Article |
id | doaj.art-1e70156a7b42418494ebdd8e49a6ca87 |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-03-11T11:11:14Z |
publishDate | 2023-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-1e70156a7b42418494ebdd8e49a6ca872023-11-12T04:00:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.12131213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settingsJun Ishihara01Imperial College London, London, UK |
spellingShingle | Jun Ishihara 1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings Journal for ImmunoTherapy of Cancer |
title | 1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings |
title_full | 1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings |
title_fullStr | 1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings |
title_full_unstemmed | 1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings |
title_short | 1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings |
title_sort | 1213 tumor ecm targeted il 12 improved safety and efficacy in clinically relevant settings |
work_keys_str_mv | AT junishihara 1213tumorecmtargetedil12improvedsafetyandefficacyinclinicallyrelevantsettings |